170 related articles for article (PubMed ID: 8077720)
1. Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis.
Bhattacharjee AK; Opal SM; Palardy JE; Drabick JJ; Collins H; Taylor R; Cotton A; Cross AS
J Infect Dis; 1994 Sep; 170(3):622-9. PubMed ID: 8077720
[TBL] [Abstract][Full Text] [Related]
2. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
[TBL] [Abstract][Full Text] [Related]
3. Immunization of cows with novel core glycolipid vaccine induces anti-endotoxin antibodies in bovine colostrum.
Cross AS; Karreman HJ; Zhang L; Rosenberg Z; Opal SM; Lees A
Vaccine; 2014 Oct; 32(46):6107-14. PubMed ID: 25242628
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical specificity of human antibodies to lipopolysaccharide from the J5 rough mutant of Escherichia coli O111:B4.
Schwartzer TA; Alcid DV; Numsuwan V; Gocke DJ
J Infect Dis; 1989 Jan; 159(1):35-42. PubMed ID: 2462603
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
Siber GR; Kania SA; Warren HS
J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
[TBL] [Abstract][Full Text] [Related]
6. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
[TBL] [Abstract][Full Text] [Related]
7. Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis.
Cross AS; Opal SM; Warren HS; Palardy JE; Glaser K; Parejo NA; Bhattacharjee AK
J Infect Dis; 2001 Apr; 183(7):1079-86. PubMed ID: 11237833
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5.
Baumgartner JD; Heumann D; Calandra T; Glauser MP
J Infect Dis; 1991 Apr; 163(4):769-72. PubMed ID: 2010630
[TBL] [Abstract][Full Text] [Related]
9. Enzyme immunoassay for the quantitation of immunoglobulin M class antibodies to Salmonella minnesota R595 and Escherichia coli J5 lipopolysaccharides.
Vanesian MA; Fung G; Bagdasarian A
Diagn Microbiol Infect Dis; 1987 Jan; 6(1):11-25. PubMed ID: 3542358
[TBL] [Abstract][Full Text] [Related]
10. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
[TBL] [Abstract][Full Text] [Related]
11. The role of heparin in guinea pig gram negative bacterial sepsis.
Dunn DL; Mach PA; Cerra FB; Ferguson RM
J Surg Res; 1983 May; 34(5):479-85. PubMed ID: 6405100
[TBL] [Abstract][Full Text] [Related]
12. Age-related prevalence of human serum IgG and IgM antibody to the core glycolipid of Escherichia coli strain J5, as measured by ELISA.
Law BJ; Marks MI
J Infect Dis; 1985 Jun; 151(6):988-94. PubMed ID: 3889174
[TBL] [Abstract][Full Text] [Related]
13. Hyperimmunization of steers with J5 Escherichia coli bacterin: effects on isotype-specific serum antibody responses and cross reactivity with heterogeneous gram-negative bacteria.
Chaiyotwittayakun A; Burton JL; Weber PS; Kizilkaya K; Cardoso FF; Erskine RJ
J Dairy Sci; 2004 Oct; 87(10):3375-85. PubMed ID: 15377616
[TBL] [Abstract][Full Text] [Related]
14. Role of normal serum in the binding of lipopolysaccharide to IgG fractions from rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
Warren HS; Glennon M; de Deckker FA; Tello D
J Infect Dis; 1991 Jun; 163(6):1256-66. PubMed ID: 1709961
[TBL] [Abstract][Full Text] [Related]
15. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
Tyler JW; Spears H; Nelson R
J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
[TBL] [Abstract][Full Text] [Related]
16. Release of gram-negative outer-membrane proteins into human serum and septic rat blood and their interactions with immunoglobulin in antiserum to Escherichia coli J5.
Hellman J; Loiselle PM; Zanzot EM; Allaire JE; Tehan MM; Boyle LA; Kurnick JT; Warren HS
J Infect Dis; 2000 Mar; 181(3):1034-43. PubMed ID: 10720528
[TBL] [Abstract][Full Text] [Related]
17. Administration in vivo of recombinant interleukin 2 protects mice against septic death.
Weyand C; Goronzy J; Fathman CG; O'Hanley P
J Clin Invest; 1987 Jun; 79(6):1756-63. PubMed ID: 3294901
[TBL] [Abstract][Full Text] [Related]
18. Antigenic crossreactivity and lipopolysaccharide neutralization properties of bovine immunoglobulin G.
Tomita GM; Todhunter DA; Hogan JS; Smith KL
J Dairy Sci; 1995 Dec; 78(12):2745-52. PubMed ID: 8675757
[TBL] [Abstract][Full Text] [Related]
19. Antibody specific for Escherichia coli J5 cross-reacts to various degrees with an Escherichia coli clinical isolate grown for different lengths of time.
McCallus DE; Norcross NL
Infect Immun; 1987 May; 55(5):1042-6. PubMed ID: 3552983
[TBL] [Abstract][Full Text] [Related]
20. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
